HSP90AA1 and hepatocellular carcinoma: Increased HSP90AA1 levels were reported to promote metastasis and increase the resistance of HCC cells to lenvatinib‐induced apoptosis, highlighting the pivotal role of NAT10 in modulating ERS‐mediated HCC progression.143